Tradestie Institutional Equity Comparison Engine

CRMD vs KALV โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KALV Overall Edge

KALV Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to KalVista Pharmaceuticals, Inc. Common Stock (KALV) driven by superior Momentum & Technical, Options & Structure while CRMD counters with relative strength in Valuation, Growth & Margin. Fundamentally, CRMD trades at 49.0x Forward P/E with 41.0% operating margin (-47.7% YoY revenue) versus KALV at 25.4x Forward P/E and -57.4% operating margin (+30.7% YoY). In options structure, CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against KALV sits in UNCLASSIFIED (31st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
CRMD 49.0x vs KALV 25.4x Fwd P/E
Growth & Margin Winner CRMD
Op Margin 41.0% vs -57.4% ยท YoY -47.7% vs +30.7%
Momentum & Technical Winner KALV
1Y -56.2% vs +82.9% ยท 52W Pos 3% vs 100%
Options & Structure Winner KALV
BREAKDOWN (25th %ile IV) vs UNCLASSIFIED (31st %ile IV)
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0
KALV NASDAQ
KalVista Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$27.00
+0.04% 1D
Market Cap $1.4B
1M Return +1.09%
1Y Return +82.93%
Forward P/E 25.4x
Unified AI Score
55.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 57.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRMD -56.16% KALV +82.93% Spread: +128.03 pp (KALV Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CRMD TTM Op. Margin: 41.0% KALV TTM Op. Margin: -57.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRMD vs KALV. Trailing 12-month operating profitability (CRMD 41.0% vs KALV -57.4%) and valuation multiples (CRMD 49.0x vs KALV 25.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRMD (4) vs KALV (6)
Institutional Metric CRMD KALV Criterion Row Winner
Market Capitalization Scale $384.7M $1.4B Larger Scale KALV
Trailing P/E Ratio Valuation 2.4x 25.4x Lower Multiple CRMD
Forward P/E Ratio Valuation 49.0x 25.4x Lower Multiple KALV
Revenue Growth (YoY) Growth -47.7% +30.7% Higher Growth KALV
Operating Margin (TTM) Profitability 41.0% -57.4% Higher Margin CRMD
Net Profit Margin Profitability 15.5% -118.7% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency 15.3% -190.2% Higher ROE CRMD
52-Week Range Position Momentum 3% ($5โ€“$13) 100% ($10โ€“$27) Stronger Trend KALV
Beta / 30D Volatility Risk Regime 1.20ฮฒ ยท 107% Vol 0.85ฮฒ ยท 2% Vol Lower Realized Risk KALV
Unified Institutional Score Composite Signal 53.2 / 100 (HOLD) 55.1 / 100 (HOLD) Higher Composite KALV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRMD vs KALV Buy Guide
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KALV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 31st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live KALV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRMD nor KALV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.